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Abstract
Background: Atherosclerosis is an inflammatory process that develops in individuals with known risk factors that include
hypertension and hyperlipidaemia, influenced by diet. However, the interplay between diet, inflammatory mechanisms and
vascular risk factors requires further research. We hypothesised that interleukin-1 (IL-1) signaling in the vessel wall would
raise arterial blood pressure and promote atheroma.
Methodology/Principal Findings: Apoe2/2 and Apoe2/2/IL-1R12/2mice were fed high fat diets for 8 weeks, and their blood
pressure and atherosclerosis development measured. Apoe2/2/IL-R12/2 mice had a reduced blood pressure and
significantly less atheroma than Apoe2/2 mice. Selective loss of IL-1 signaling in the vessel wall by bone marrow
transplantation also reduced plaque burden (p,0.05). This was associated with an IL-1 mediated loss of endothelium-
dependent relaxation and an increase in vessel wall Nox 4. Inhibition of IL-1 restored endothelium-dependent vasodilatation
and reduced levels of arterial oxidative stress.
Conclusions/Significance: The IL-1 cytokine system links atherogenic environmental stimuli with arterial inflammation,
oxidative stress, increased blood pressure and atherosclerosis. This is the first demonstration that inhibition of a single
cytokine can block the rise in blood pressure in response to an environmental stimulus. IL-1 inhibition may have profound
beneficial effects on atherogenesis in man.
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Introduction
Drugs to decrease plasma lipid levels and blood pressure are the
basis of the medical treatment strategy for cardiovascular disease.
Dietary modification of macronutrient and salt intakes has also
been studied with some large effects upon systolic blood pressure
in particular [1–3]. However, the exact interplay between the well-
described plaque-based inflammatory processes of atherogenesis
[2,4] and the conventional risk factors of lipids and blood pressure
remains poorly understood. We hypothesized that the pro-
inflammatory cytokine interleukin-1 (IL-1), known to have an
association with atherosclerosis, is the link between vascular
responses and high fat feeding.
In the arterial wall, IL-1 is secreted primarily by monocytes
and macrophages but also by endothelial and smooth muscle
cells [5,6]. IL-1 is an apical cytokine initiating inflammatory
signals from bacterial products, chemical injury, complement
activation and clotting factors. There are two agonistic cytokines,
IL-1a and b which both signal via the type-I IL-1 receptor (IL-
1R1). The system is tightly regulated by a natural antagonist,
interleukin-1 receptor antagonist (IL-1ra) which also binds to IL-
1R1 but does not produce a signal, and a non-signaling cell
surface receptor, IL-1 receptor type-II, which acts as a decoy at
the cell membrane or when shed as a soluble circulating decoy
receptor [7,8].
IL-1 is a powerful inflammatory stimulus to endothelial and
vascular smooth muscle cells with effects that are plausibly linked
with known mechanisms of atherogenesis [9]. Levels of IL-1 are
increased in coronary arteries affected by atherosclerosis [10,11],
and inhibition of IL-1 in animal models is associated with reduced
amounts of atheroma [12–16] as well as neointima following
angioplasty [17]. Excess IL-1 leads to vascular cell oxidative stress,
which is linked with elevation of arterial blood pressure mediated
by adverse effects of oxidative stress upon bioavailable nitric oxide.
We report here the cardiovascular effects of abolishing IL-1
signaling either by genetic deletion of IL-1R1 or by administration
of IL-1ra in proatherogenic Apoe2/2 mice fed atherogenic diets.
We also show a link between fat feeding and blood pressure that is
mediated via IL-1 through modulation of the NADPH-oxidase
subunit 4 (Nox 4).
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Materials and Methods
More detailed methods can be found in the online supplemental
material (Text S1).
Animals
Apoe2/2/IL-R12/2 mice were generated at JAX labs by cross
breeding of Apoe2/2 (JAX 2052) with IL-R12/2 (JAX 3245) mice.
All mice were on a C57BL/6 background. Male mice, 8 weeks of
age, (12 per group) were fed normal chow (4.3% fat, 0.02%
cholesterol), Western diet (21% fat, 0.15% cholesterol, 0.03%
cholate, 0.296% sodium) or Western High Cholate (WHC or
Paigen) diet (18.5% fat, 0.9% cholesterol, 0.5% cholate, 0.259%
sodium) for 8 weeks. No differences in body weights between the
strains were observed either with or without fat feeding. Diets were
supplied by Special Diet Services, UK. All animal experiments
were approved by the University of Sheffield Project Review
Committee and conformed to UK Home Office ethical guidelines.
Quantification of Atherosclerotic Lesions
Histologically stained paraffin wax embedded sections were
analysed as previously described [18].
Blood Pressure Analysis
Systolic and diastolic blood pressures of mice were measured
using a Visitech tail-cuff system (Visitech Systems, NJ, USA) and
mean blood pressure calculated (supplementary text S1).
Arteriolar Myogenic Reactivity and Responsiveness to
Nitric Oxide
A pressure myograph system (Living Systems Instrumentation,
USA) was used to determine arteriolar myogenic reactivity and
responsiveness to nitric oxide, as previously described [19,20].
Bone Marrow transplantation
Irradiation and bone marrow transplantation of mice was
performed as previously described [18] (text S1).
Detection of Reactive Oxygen Species (ROS), NOS and
Nitric Oxide
Superoxide production in mouse aortic tissue sections was
detected in-situ [21]. Levels of ROS in aortic tissue were
determined by chemiluminescent assay [22]. Nitric oxide synthase
(NOS) enzymatic activity, and indirectly nitric oxide (NO)
synthesis, was measured by the conversion of 14C L-arginine to
14C L-citrulline [23]. These methods are given in detail in the
supplementary data. NO bioactivity in mice fed WHC was
determined using an enzyme immunoassay for cyclic guanosine
monophosphate (cGMP) (Cayman Chemical, UK).
Quantitative Real time polymerase chain reaction
Quantification of Nox 2 and Nox 4 was performed by
amplification of artery cDNA using a MX3000P instrument
(Stratagene) with SYBR green dye, and normalization to 18S
rRNA. For cultured cells, normalization was to b-actin. Optimized
amplification conditions were 150 mmol/L primers, 2.5 mmol/L
MgCl2, annealing at 60uC and extension at 72uC. Primer
sequences were as described in [24].
Statistical Analysis
Data groups were analyzed by t-test or one-way ANOVA
followed by a Bonferroni multiple comparison post-test, as
appropriate. Blood pressure measurements were analyzed by
global non-linear regression, followed by an F-test. Vessel
diameters were analyzed by two-way repeated-measures ANOVA.
pD2, Emax, L-NAME effects and wall: lumen ratios were compared
by t-tests. Data are presented as mean6SEM. p,0.05 was
regarded as a significant difference.
Results
Further results can be found in the online supplementary text
(Results S1).
Effects of genetic deletion of IL-1R1 and diet type on
atherosclerosis lesion development
As expected, Apoe2/2 mice fed high fat diets displayed
significant increases in atherosclerotic lesion area compared to
mice fed chow, with the Western diet with high cholate (WHC)
causing the a greatest increase (Figure 1a). In contrast, lesions
developed by Apoe2/2/IL-R12/2 mice fed these high fat diets
were not significantly different to Apoe2/2/IL-R12/2 mice fed on
chow. Analysis of each different diet type separately revealed no
significant difference in lesion area of Apoe2/2 and Apoe2/2/IL-
R12/2 mice fed chow (p= 0.3), or Western diet (p = 0.4).
However, when fed the WHC diet, Apoe2/2/IL-R12/2 mice
developed a 36% smaller atherosclerotic lesion in the aortic sinus
compared to Apoe2/2 mice (p,0.001) (Figure 1a). Representative
images of the microscopic appearance of the lesions are shown in
Figure S1. Characterisation of the lesions revealed no overt
differences with respect to strain or diet (Results S1, table S1,
Table S2, figure S2). Body weight did not differ between mice of
any group (data not shown).
Atherosclerotic lesion formation in IL-1R1 chimeric mice
fed a WHC diet
Apoe2/2 and Apoe2/2/IL-R12/2 chimeric mice were used to
determine the relative contribution of IL-1 signaling in cells
derived from the bone marrow and non-bone marrow (tissue cells)
upon the development of atherosclerosis following fat feeding.
Irradiated Apoe2/2 mice receiving Apoe2/2 bone marrow had
large, and Apoe2/2/IL-R12/2 mice receiving Apoe2/2/IL-R12/2
marrow relatively little, atherosclerosis in their aortic sinus
following 8 weeks on a WHC diet, as expected and analogous to
Apoe2/2 and Apoe2/2/IL-R12/2 non-chimeric animals.
Interestingly, Apoe2/2 animals receiving Apoe2/2/IL-R12/2
bone marrow (i.e. chimera is capable of IL-1 signaling in vessel
wall/tissue cells) did not develop a lesion that was significantly
different from Apoe2/ mice receiving Apoe2/2 marrow (Figure 1b).
In contrast, Apoe2/2/IL-R12/2 mice receiving Apoe2/2 bone
marrow (i.e. chimera is not able to signal via IL-1 in vessel wall/
tissue cells) developed a 1.9-fold smaller lesion than the Apoe2/2 to
Apoe2/2 controls (p,0.05). The lesion size between Apoe2/2/IL-
R12/2 into Apoe2/2 and Apoe2/2 into Apoe2/2/IL-R12/2 mice
also differed significantly (p,0.05) (Figure 1b).
Pathological analysis, by chromosome painting, of these animals
showed all had engrafted donor marrow (figure S3).
Blood pressure responses to fat feeding
There was no difference in mean blood pressure in Apoe2/2/IL-
R12/2 mice fed the Western, WHC or chow diet (figure 2a).
However, Apoe2/2 mice fed high fat diets had increased blood
pressure compared with chow fed animals, with WHC-fed mice
having a greater elevation than Western fed animals (p,0.05
WHC vs Western or chow)(figure 2b).
When comparing mouse strains, no difference was seen in mean
blood pressure between Apoe2/2/IL-R12/2 or Apoe2/2 fed a
IL-1 Modulates Blood Pressure
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normal chow diet over an 8-week period (p =ns)(figure 2c).
However, on feeding high fat diets, Apoe2/2/IL-R12/2 mice fed
either the Western or WHC diet had a significantly lower blood
pressure (a level comparable to Apoe2/2 mice on chow diet) than
the Apoe2/2 mice fed the equivalent diet (p,0.001; p,0.0001
respectively, figure 2d, 2e).
Apoe2/2 mice on WHC diets infused with IL-1ra using an
osmotic pump also had a significantly lower blood pressure than
Apoe2/2 mice given placebo (Figure 2f). Elevations of IL-1ra in
these animals was confirmed by ELISA, and found to be 1435.1+/
2118.7 pg/ml compared to 0.215+/20.1452 pg/ml in placebo
mice.
Effect of IL-1R1 deletion on vascular reactivity and
compliance in mice fed WHC diet
Mesenteric arteries from Apoe2/2 and Apoe2/2/IL-R12/2 mice
fed Western and WHC diets did not differ in their sensitivity to
phenylephrine (PE) (table S3). However, preconstricted arteries
from Apoe2/2/IL-R12/2 mice fed these diets displayed signifi-
cantly greater vasodilator sensitivity to acetyl choline (ACh)
(p,0.05; Figures 3a and b) compared to Apoe2/2 animals. The
vasodilatory response to ACh was also significantly different
between chow, Western and WHC diets in Apoe2/2 mice
(p,0.05). In Apoe2/2/IL-R12/2 mice fed WHC diet there was
greater constriction (19.1+/21.3%) compared to Apoe2/2 (8.6+/
22.7%) following incubation with N(G)-nitro-L-arginine methyl
ester (L-NAME) (p= 0.003), without a significant difference
between pD2 (negative logarithm of EC50: concentration required
for half maximum response) (table S3).
Both Apoe2/2 and Apoe2/2/IL-R12/2 mice demonstrated
similar internal luminal diameters of small mesenteric arteries
increased in response to increasing intraluminal pressure (active
response), with Apoe2/2 mice fed either diet showing a trend
towards a reduced myogenic response (figure S4a, S4b). However,
only Apoe2/2/IL-R12/2 mice fed WHC diet demonstrated a
greater active pressure-diameter response compared to chow fed
Apoe2/2 mice (figure S4a).
There was no difference in the wall-to-lumen ratio (vascular
smooth muscle thickness/external diameter at 80 mmHg; h/R)
[19] between the two groups (0.115+/20.007 Apoe2/2/IL-R12/2
vs 0.111+/20.011 Apoe2/2, n = 6). Endothelium-independent
relaxation responses, assessed by superfusion of sodium nitroprus-
side (SNP), also did not differ (figure 3c).
Effect of IL-1R1 deletion on NO activity, ROS, NOS and
NOX expression in mice fed WHC diet
The induction of Nox4 mRNA and generation of ROS in
response to IL-1 stimulation was confirmed in arteriolar
endothelial cells (Figure S5). ROS were not generated in response
to IL-1 in endothelial cells isolated from Apoe2/2/IL-R12/2 mice
(figure S5). In contrast, Nox 4 mRNA was reduced in IL-1
stimulated vascular smooth muscle cells (VSMC) (figure S6) as
previously shown [25].
The vessel wall mechanisms that could contribute to the
observed vascular reactivity effects were investigated by examining
the expression of NO, ROS, NOS and Nox isoforms in WHC
diet-fed animals, as this diet gave the largest difference in blood
pressure and atheroma between animals with and without the
ability to signal via IL-1R1.
NO bioactivity was increased in Apoe2/2/IL-R12/2 mice fed a
WHC diet compared with WHC fed Apoe2/2 mice (n= 9–11,
p,0.05) (Figure 4a). Activity of eNOS in the presence or absence
of eNOS co-factors did not differ between Apoe2/2/IL-R12/2
mice fed a WHC diet compared with Apoe2/2 mice (p= ns)
(Figure 4b). Qualitative in situ detection of ROS showed
production in atherosclerotic plaques was reduced in Apoe2/2/
IL-R12/2 compared to Apoe2/2 mice fed WHC diet (Figure 4c).
Quantitative measurement of aortic ROS production showed
ROS to be significantly reduced in Apoe2/2/IL-R12/2 mice on a
WHC diet (n = 9, p,0.05)(Figure 4d). ROS production was also
suppressed in Apoe2/2 mice on a WHC diet by a 4-week infusion
Figure 1. Atherosclerosis formation in mice following feeding
of a high fat diet. Atherosclerotic lesion area in the aortic sinus of
Apoe2/2 and Apoe2/2/IL-R12/2 mice (a) and chimeric mice (b) fed a
high fat and chow diets. ApoeRDN denotes Apoe2/2/IL-1R12/2 (DN)
mice receiving Apoe2/2 bone marrow (n = 3); DNRApoe denotes
Apoe2/2 mice receiving Apoe2/2/IL-1R12/2 marrow (n = 9).
doi:10.1371/journal.pone.0005073.g001
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of IL-1ra (n = 3, p,0.05)(Figure 4e). Generation of ROS in
response to feeding a high fat diet was also confirmed (figure S7).
Apoe2/2 mice fed WHC had significantly more ROS than those
fed chow alone, with Western diet giving intermediate levels of
ROS. ROS levels were also significantly higher in Apoe2/2/IL-
R12/2 mice fed WHC compared to chow (0.85+/20.14
compared to 0.51+/20.30 LU/g tissue, n= 9, p,0/01).
Nox 4 expression in the whole arterial wall was significantly
reduced in Apoe2/2/IL-R12/2 mice fed the WHC diet compared
to Apoe2/2 mice (Figure 5a). Expression of Nox 1 and 2 however,
did not differ between these two mouse strains on this diet
(figure 5b, 5c).
Discussion
The Apoe2/2 mouse fed a high fat diet is an established model of
atherogenesis. On a Western or a Western high cholate diet
(WHC, sometimes called the Paigen diet), Apoe2/2 mice develop
aortic atheroma [26] and blood pressure is known to rise within 1
to 3 months of feeding. We show here that IL-1 inhibition reduces
atheroma formation and prevents the associated rise in blood
pressure in Apoe2/2 mice fed high fat diets.
IL-1 inhibition was achieved by generating mice deficient for
both Apoe and IL-1 receptor 1 (IL-1R1) genes. As expected, aortic
atheroma was significantly reduced in Apoe2/2/IL-R12/2 mice
Figure 2. Blood pressure of mice following feeding of a high fat diet.Mean blood pressure in Apoe2/2/IL-1R12/2 (a) and Apoe2/ (b)mice fed
all 3 diets, and Apoe2/2/IL-1R12/2 compared to Apoe2/2 mice fed chow (c) Western (d) and WHC (e). (f) Mean blood pressure in Apoe2/2 mice
administered with hrIL-1ra or placebo, fed WHC diet. n = 4 for all groups.
doi:10.1371/journal.pone.0005073.g002
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fed WHC compared with Apoe2/2 controls. This is in agreement
with previous studies that showed decreased atherosclerosis in IL-
1b2/2 and IL-1a2/2 mice fed a high cholate diet [27] and with
data from a heterozygote Apoe2/2 model [16]. In addition, both
high fat diets were associated with increased markers of
inflammation that were attenuated in Apoe2/2/IL-1R12/2 mice
(Results S1). Interestingly, IL-1b and IL-1ra plasma levels in mice
were not changed in response to fat-feeding, This was not
unexpected: mature plasma IL-1b is a difficult parameter to
interpret as a non-secreted protein and IL-1ra behaves as an acute
phase reactant with a large variation in levels [28]. Any true
changes in inflammatory markers are more likely to occur locally
within the vessel wall itself.
Apoe2/2 mice fed a high fat diet display a rise in blood pressure
that is not seen in Apoe2/2/IL-R12/2 mice fed equivalent diets.
The specificity of this was confirmed by abolition of the fat-feeding
induced blood pressure rise in Apoe2/2 mice given IL-1ra. Stroke-
prone spontaneously hypertensive rats (SHRSP) showed no
difference in blood pressure if given IL-1ra (data not shown),
suggesting that IL-1ra does not act as a non-specific vasodilator.
To study the mechanism of the attenuation of the blood
pressure rise in the Apoe2/2/IL-R12/2 mice we investigated active
arteriolar pressure-diameter responses and basal and agonist-
induced NO production in Apoe2/2 and Apoe2/2/IL-R12/2 fat-
fed mice. The greater vessel diameter in response to increasing
pressure in vessels from Apoe2/2/ILR12/2, together with no
observed difference in sensitivity to PE between groups or in
vascular smooth muscle constriction for the given degree of muscle
shortening (wall: lumen ratio), as well as the preserved response to
SNP, all suggest a specific endothelial response.
The strikingly preserved agonist-induced NO dependent
vasodilatation of resistance vessels from Apoe2/2/IL-1R12/2 mice
compared to Apoe2/2 in both diet groups as well as the greater
contraction in response to L-NAME in the fat-fed Apoe2/2/IL-
1R12/2 mice indicate a fundamental increase in bioavailable
vessel wall nitric oxide as a result of selective loss of IL-1 signaling.
This is emphasised by the observed increase in basal cGMP
production seen in these mice. The activity of eNOS, in the
presence or absence of eNOS co-factors, did not differ between the
two mouse strains suggesting that the difference in bioavailable
NO attributable to selective IL-1 inhibition is mediated by
increased consumption of NO via increased arterial oxidative
stress.
In support of these data, there was consistent reduction of
arterial ROS levels in mice unable to signal via IL-1. Investigation
of Nox isoforms, known to regulate NADPH activity [29,30],
indicated a Nox-4 selective rise in response to fat feeding in the
Apoe2/2 mouse attenuated by abolition of IL-1 signaling. Taken
together, these results suggest a central role for IL-1 in modulating
the blood pressure response to high lipids and that this is via a
selective reduction in bioavailable nitric oxide.
The chimeric mouse experiments were conducted to examine
the compartment in which IL-1 signaling was important. Only in
chimeras where tissue cells were unable to signal via IL-1 was a
there a decrease in atherosclerotic lesion size. These data
complement a recent study by Kamari et al. who showed reduced
atherosclerosis in wild type, WHC-fed mice reconstituted with
either IL-1b2/2 or IL-1a2/2 bone marrow [27].
We also demonstrate that vessel wall ROS production and Nox 4
levels are altered between the non-chimeric Apoe2/2 and Apoe2/2/
Figure 3. Vascular reactivity of arterioles from Apoe2/2 and
Apoe2/2/IL-R12/2 mice. (a–b) % maximum dilation of pre-constricted
mesenteric arterioles (EC80PE) to acetylcholine. (c) Endothelium-
independent relaxation responses assessed by superfusion of sodium
nitroprusside (SNP) were not different between Apoe2/2 and Apoe2/2/
IL-R12/2 mice both fed a WHC diet (n = 6 per group).
doi:10.1371/journal.pone.0005073.g003
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IL-1R12/2 strains on high fat diets. The myography experiments
also suggest a selective endothelial loss of function. Thus, the
data presented here add to the hypothesis that IL-1 signaling
within the blood vessel wall cells is the mechanism involved in the
blood pressure and atherogenic responses to fat feeding in Apoe2/2
mice.
Our studies examined the effects of two different pro-
atherogenic diets, administered for 8 weeks. Of these diets, the
WHC diet is known to be the most aggressive, giving a chronic
inflammatory response compared to the acute response of a
standard Western (high cholesterol/low cholate) diet [31]. Besides
being a normal component of bile in vertebrates, cholate (E1000)
is an emulsifier and foam stabilizing agent used in food
manufacturing which leads to very high circulating cholesterol
concentrations in plasma. Given the difference in plasma
cholesterol load, it is interesting that the poor vascular reactivities
of vessels from mice fed both diets were similar with a clear gain of
function seen in mice lacking the ability to signal via IL-1R1,
irrespective of the cholate content. Atheroma development and
blood pressure elevation were graded in magnitude through chow
to the Western and WHC diets, with the WHC having the greatest
effect. In keeping with this, the greatest level of attenuation of
biological events by IL-1 inhibition was seen in the WHC diet fed
animals. These all suggest a specificity of IL-1 in the mediation of
fat fed vascular events.
The WHC diet can cause intense metabolic disruption, hepatic
dysfunction and inflammatory activation. We did not see these
effects. Additionally, we saw similar index data (e.g. blood pressure
and atheroma formation) for mice fed on the Western and the
WHC diet, though the magnitude of the blood pressure effects was
reduced with the Western diet. We feel, therefore, that where we
have used the WHC diet for further detailed experimentation that
this is justified and that the results derived are the result of
elevation in cholesterol: the Western diet giving intermediate
cholesterol levels and intermediate phenotype, and the WHC diet
giving rise to high cholesterol and an advanced phenotype.
There is considerable interest in harnessing knowledge of basic
inflammatory mechanisms of atherogenesis for therapeutic benefit.
We show that dietary manipulation in a murine model of
atherosclerosis is associated with a rise in blood pressure, an effect
attenuated by selective inhibition of a single cytokine. High fat
diets may be particularly linked with elevation in blood pressure
Figure 4. NO activity, ROS and NOS expression in mice fed WHC diet. (a) cGMP in lung homogenates (n = 14), (b) eNOS enzymatic activity
(n = 6) and (c) in-situ ROS (white arrowhead) in Apoe2/2/IL-R12/2 and Apoe2/2 mice fed WHC. (Note: images chosen illustrate ROS levels not
atherosclerotic lesion size). Chemiluminescent quantification of ROS in mice fed WHC (d) and Apoe2/2 mice fed WHC diet (n = 9) and administered
hrIL-1ra (n = 4) (e).
doi:10.1371/journal.pone.0005073.g004
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[3,32]. It is clear that in humans, dietary alterations away from a
standard Western diet to those lower in fat, but which are
isocaloric and balanced for sodium content, or which are
supplemented with omega-3 fatty acids, also lower blood pressure
[1,33–35]. Omega-3 fatty acids have also been shown to reduce
cyclooxygenase-2 and NADPH oxidase activity [36], both of
which are induced by IL-1. This suggests that the link between diet
and blood pressure may be through the IL-1 cytokine system, and
may indicate a role for IL-1 inhibition in the control of
hypertension in man.
In our experiments, there was a concomitant reduction in blood
pressure and atheroma development. In fat-fed Apoe2/2 mice,
development of atheroma is not driven directly by the rise in blood
pressure [37]. It seems likely therefore, that the IL-1 mediated
increase in ROS and decreased NO production are the central
mechanism of atheroma development as both of these have
individually been implicated in atherogenesis. The absence of
difference in lipid levels between the different mouse strains on the
same diets (results S1) confirms the likely effect of IL-1 inhibition
on atherogenesis being a ROS/NO-based mechanism.
These data raise the possibility of an entirely novel strategy for
prevention of atherosclerosis. An anti-IL-1 based approach would
be expected to have a beneficial effect upon atherogenic
mechanisms at multiple levels. Indeed, very recent data have
indicated a beneficial effect of IL-1ra upon patients with type II
diabetes [38], ventricular function [39] and myocardial infarction
in mice [40] and a similar approach might allow mitigation of the
atherogenic potential of Western diets. We anticipate that targeted
pharmacological intervention to inhibit IL-1 in man will be
beneficial in preventing atheroma development and the clinical
consequences that arise from this important disease of developed
nations.
Supporting Information
Text S1 Expanded methods.
Found at: doi:10.1371/journal.pone.0005073.s001 (0.04 MB
DOC)
Results S1 Additional data
Found at: doi:10.1371/journal.pone.0005073.s002 (0.04 MB
DOC)
Figure S1 Microscopic appearances around the aortic sinus of
ApoE2/2 mice fed chow, Western, and WHC compared with
ApoE2/2/IL-1R12/2 mice. Original magnification62.
Found at: doi:10.1371/journal.pone.0005073.s003 (1.18 MB TIF)
Figure S2 Modulation of IL-1 signaling decreases acute phase
reactant serum amyloid A (SAA) levels. SAA was elevated in
Apoe2/2 mice on both high fat diets, an increase that was
significantly reduced in the Apoe2/2/IL-R12/2 mice on
equivalent diets. (n = 9–20)
Found at: doi:10.1371/journal.pone.0005073.s004 (4.80 MB TIF)
Figure S3 Chromosome painting of bone-marrow transplanted
mice. No Y-chromosomes were seen in male mice transplanted
with female bone marrow, confirming engraftment was successful.
Male recipients of male bone marrow all have Y-chromosomes, as
expected, as a positive control for this method.
Found at: doi:10.1371/journal.pone.0005073.s005 (2.45 MB TIF)
Figure S4 Vascular reactivity of arterioles from Apoe2/2 and
Apoe2/2/IL-R12/2 mice. Intraluminal arteriolar diameter
in response to increasing pressure (0–120 mmHg). *P,0.05
Apoe2/2/IL-R12/2 (n = 6) and **P,0.05 Apoe2/2 WHC
(n= 6) versus Apoe2/2 chow (n = 4).
Figure 5. Nox expression following feeding of WHC diet.
Expression of Nox is selectively reduced in Apoe2/2/IL-R12/2 mice fed
WHC. (a) qRT-PCR shows reduced (p,0.05) levels of Nox 4 in the
vascular wall of Apoe2/2/IL-R12/2 mice fed WHC diet. Levels of Nox 2
(b) and Nox 1 (c) do not differ. n = 12 per group.
doi:10.1371/journal.pone.0005073.g005
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Found at: doi:10.1371/journal.pone.0005073.s006 (0.61 MB TIF)
Figure S5 ROS and Nox 4 expression in endothelial cells in
culture. Increased ROS are seen following IL-1b stimulation of
endothelial cells isolated from Apoe2/2 mice (n= 6) (a) and
human coronary endothelial cells (hCAEC) (n = 6) (b). However,
no increase in ROS are seen in ECs isolated from Apoe2/2/IL-
1R12/2 mice (n= 6) (a). Nox 4 mRNA expression is increased in
hCAEC stimulated with IL-1b (n = 5) (c).
Found at: doi:10.1371/journal.pone.0005073.s007 (9.90 MB TIF)
Figure S6 ROS and Nox 4 expression in vascular smooth
muscle cells in culture. No significant difference in ROS are seen
following IL-1b stimulation of VSMCs (n= 6) (a). Nox 4 mRNA
expression is decreased in VSMC stimulated with IL-1b (n = 1) (b).
Found at: doi:10.1371/journal.pone.0005073.s008 (0.30 MB TIF)
Figure S7 ROS generation in Apoe2/2 mice following feeding
of a high fat diet. Mice fed WHC had significantly more ROS than
those fed chow alone, with Western diet giving intermediate levels
of ROS. (n = 9).
Found at: doi:10.1371/journal.pone.0005073.s009 (2.79 MB TIF)
Table S1 Lipid, glucose and ALT levels in ApoE2/2/IL-1R12/2
and ApoE2/2 mice fed chow, Western High Cholate (WHC), and
Western diets. Data represents mean+/2SEM.
Found at: doi:10.1371/journal.pone.0005073.s010 (0.05 MB
DOC)
Table S2 Plasma levels of IL-1ra, IL-1b, IL-1a and IL-6 in
ApoE2/2/IL-1R12/2 and ApoE2/2 mice fed chow, Western
high cholate (WHC), and Western diets, determined by ELISA.
Data represents mean+/2SEM.
Found at: doi:10.1371/journal.pone.0005073.s011 (0.04 MB
DOC)
Table S3 Potency and efficacy of vasoconstrictor response to
phenylephrine in pressurised mesenteric arterioles from Apoe2/2/
IL1R12/2 and Apoe2/2 mice fed a Western high cholate (WHC),
Western, or Apoe2/2 mice fed chow diet, assessed by pD2
(negative logarithm of EC50: concentration required for half
maximum response) and Emax (percentage maximum constric-
tion). All data are means+SEM. p= ns.
Found at: doi:10.1371/journal.pone.0005073.s012 (0.04 MB
DOC)
Acknowledgments
The authors thank Nadine Arnold, Dr Andrea King, Dr Victoria Ridger,
Dr Karim Jetha (Univ Sheffield), Dr Kim Suvarna (Department of
Histopathology, Northern General Hospital, Sheffield, UK) for their
contribution towards this manuscript. Amgen Inc provided the IL-1ra used
in this study.
Author Contributions
Conceived and designed the experiments: JC SEF ZB DG NA SD DC.
Performed the experiments: JC SEF ZB GS DG NA SD DC. Analyzed the
data: JC SEF ZB GS DG NA SD DC. Wrote the paper: JC SEF ZB DG
NA SD DC.
References
1. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, et al. (2005) Effects of
protein, monosaturated fat, and carbohydrate intake on blood pressure and serum
lipids: results of the OmniHeart randomized trial. JAMA 294: 2455–2464.
2. Hansson GK (2005) Inflammation, Atherosclerosis and Coronary artery Disease.
N Engl J Med 352: 1685–1695.
3. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, et al. (2006)
Lifestyle interventions to reduce raised blood pressure: a systematic review of
randomized controlled trials. J Hypertens 24: 215–233.
4. Glass CK, Witztum JL (2001) Atherosclerosis: The Road Ahead. Cell 104:
503–516.
5. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA (1984)
Interleukin-1 induces biosynthesis and cell surface expression of procoagulant
activity in human vascular endothelial cells. J Exp Med 160: 618–623.
6. Libby P, Ordovas JM, Birinyi LK, Auger KR, Dinarello CA (1986) Inducible
interleukin-1 gene expression in human vascular smooth muscle cells. J Clin
Invest 78: 1432–1438.
7. Colotta F, Dower SK, Sims JE, Mantovani A (1994) The Type II ‘decoy’
receptor ; a novel regulatory pathway for IL-1. Immunol Today 15: 562–526.
8. Symons JA, Young PR, Duff GW (1995) Soluble type II IL-1 receptor binds and
blocks processing of IL-1beta precursor and loses affinity for IL-1ra. Proc Natl
Acad Sci USA 92: 1714–1718.
9. Tamaru M, Tomura K, Sakamoto S, Tezuka K, Tamatani T, et al. (1998)
Interleukin-1 beta induces tissue- and cell-specific expression of adhesion
molecules in vivo. Arterioscler Thromb Vasc Biol 18: 1292–1303.
10. Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, et al. (1996) IL-1beta
in the coronary arteries of patients with ischaemic heart disease. Arterioscler
Thromb Vasc Biol 16: 1000–1006.
11. Dewberry R, Holden H, Crossman D, Francis S (2000) Interleukin-1 receptor
antagonist expression in human endothelial cells and atherosclerosis. Arterioscler
Thromb Vasc Biol 20: 2394–2400.
12. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, et al. (2003) Lack of interleukin-
1b decreases the severity of atherosclerosis in Apo-E deficient mice. Arterioscler
Thromb Vasc Biol 23: 656–660.
13. Elhage R, Maret A, Pieraggi MT, Thiers JC, Arnal JF, et al. (1998) Differential
effects of interleukin-1 receptor antagonist and tumor necrosis factor binding
protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation
97: 242–244.
14. Isoda K, Sawada S, Ishigami N, Matsuki T, Miyazaki K, et al. (2004) Lack of
interleukin-1 receptor antagonist modulates plaque composition in apolipopro-
tein E-deficient mice. Arterioscler Thromb Vasc Biol 24: 1068–1073.
15. Devlin CM, Kuriakose G, Hirsch E, Tabas I (2002) Genetic alterations of IL-1
receptor antagonist in mice affect plasma cholesterol level and foam cell lesion
size. Proc Natl Acad Sci USA 99: 6280–6285.
16. Chi H, Messas E, Levine RA, Graves DT, Amar S (2004) IL-1 Receptor
signaling mediates atherosclerosis associated with bacterial exposure and/or
high fat diet in a murine apolipoprotein E Heterozygote model. Circulation 110:
1678–1685.
17. Morton AC, Arnold ND, Gunn J, Varcoe R, Francis SE, et al. (2005)
Interleukin-1 receptor antagonist alters the response to vessel wall injury in a
porcine coronary artery model. Cardiovasc Res 68: 493–501.
18. Chamberlain J, Evans D, Dower S, Crossman D, Francis S (2006) IL-1b and
signaling of IL-1 in vascular wall and circulating cells modulates the extent of
neointima formation after vascular injury in mice. Am J Pathol 168: 1396–1403.
19. Brookes ZL, Kaufman S (2003) Myogenic responses and compliance of
mesenteric and splenic vasculature in the rat. Am J Physiol Regul Integr Comp
Physiol 284: R1604–R1610.
20. Andrew PS, Kaufman S (2003) Guanylyl cyclase mediates ANP-induced
vasoconstriction of murine splenic vessels. Am J Physiol Regul Integr Comp
Physiol 284: R1567–R1571.
21. Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM (2004) Increased
endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohy-
drolase I overexpression reduces endothelial dysfunction and atherosclerosis in
ApoE-knockout mice. Arterioscler Thromb Vasc Biol 24: 445–450.
22. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, et al. (2001)
Endothelial regulation of vasomotion in ApoE-deficient mice. Implications for
interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103:
1282–1288.
23. Alp NJ, Mussa S, Khoo J, Cai S, Guzik T, et al. (2003) Tetrahydrobiopterin-
dependent preservation of nitric oxide-mediated endothelial function in diabetes
by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112:
725–735.
24. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, et al. (2006) Coronary
artery superoxide production and Nox isoform expression in human coronary
artery disease. Arterioscler Thromb Vasc Biol 26: 333–339.
25. Ellmark SH, Dusting GJ, Fui MW, Guzzo-Pernell N, Drummond GR (2005)
The contribution of Nox 4 to NADPH oxidase activity in mouse vascular
smooth muscle. Cardiovascular Research 65: 495–504.
26. Getz GA, Reardon CA (2006) Diet and murine atherosclerosis. Arterioscler
Thromb Vasc Biol 26: 242–249.
27. Kamari Y, Werman-Venkert R, Shaish A, Werman A, Harari A, et al. (2007)
Differential role and tissue specificity of interleukin-1a gene expression in
atherogenesis and lipid metabolism. Atherosclerosis 195: 31–38.
28. Ray KK, Camp NJ, Benett CE, Francis SE, Crossman DC (2002) Genetic
variation at the IL-1 locus is a determinant of changes in soluble endothelial
factors in patients with acute coronary syndromes. Clinical Science 103:
303–310.
IL-1 Modulates Blood Pressure
PLoS ONE | www.plosone.org 8 April 2009 | Volume 4 | Issue 4 | e5073
29. Bedard K, Krause K-H (2007) The NOX family of ROS-generating NADPH
oxidases: Physiology and Pathophysiology. Physiol Rev 87: 245–313.
30. Kaur J, Dhaunsi GS, Turner RB (2004) Interleukin-1 and Nitric Oxide increase
NADPH oxidase activity in human coronary artery smooth muscle cells.
Medical Principles and Practice 13: 26–29.
31. Vergnes L, Phan J, Strauss M, Tafuri S, Reue K (2003) Cholesterol and cholate
components of an atherogenic diet induce distinct stages of hepatic inflammatory
gene expression. J Biol Chem 278: 42774–42784.
32. Wilde DW, Massey KD, Walker GK, Vollmer A, Grekin RJ (2000) High-fat diet
elevates blood pressure and cerebrovascular muscle Ca(2+) current. Hyperten-
sion 35: 832–837.
33. Morris MC, Sacks F, Rosner B (1993) Does fish oil lower blood pressure? A
meta-analysis of controlled trials. Circulation 88: 523–533.
34. Takeuchi H, Sakurai C, Noda R, Sekine S, Murano Y, et al. (2007)
Antihypertensive effect and safety of dietary alpha-linolenic acid in subjects
with high-normal blood pressure and mild hypertension. J Oleo Sci 56: 347–360.
35. Yang H, Kenny A (2007) The role of fish oil in hypertension. Conn Med 71:
533–538.
36. Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, et al. (2006) The
omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2
induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc
Natl Acad Sci USA 103: 15184–15189.
37. Chen J, Kuhlencordt PJ, Astern J, Gyurko R, Huang PL (2001) Hypertension
does not account for the accelerated atherosclerosis and development of
aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double
knockout mice. Circulation 104: 2391–2394.
38. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, et al. (2007)
Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:
1517–1526.
39. Ikonomidis I, Lekakis JP, Nikolaou M, Paraslevaidis I, Andreadou I, et al. (2008)
Inhibition of IL-1 by Anakinra improves vascular and LV function in patients
with rheumatoid arthritis. Circulation 117: 2662–2669.
40. Abbate A, Salloum FN, Vecile E, Das A, Koke NH, et al. (2008) Anakinra, a
recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in
experimental acute myocardial infarction. Circulation 117: 2670–2683.
IL-1 Modulates Blood Pressure
PLoS ONE | www.plosone.org 9 April 2009 | Volume 4 | Issue 4 | e5073
